Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein
- PMID: 8891480
- DOI: 10.1007/BF00168488
Mediation of signal transduction in keratinocytes of human middle ear cholesteatoma by ras protein
Abstract
Immunolocalization was used to investigate the distribution of ras protein in both congenital and acquired cholesteatoma tissues. A pathological feature of middle ear cholesteatoma included accumulation of keratin debris due to active proliferation and differentiation of keratinocytes. Ras protein localized to the inner plasma membrane and cytoplasm of keratinocytes in all of the epithelial layers in both congenital and acquired cholesteatoma specimens. Keratinocytes in the basal layer were stained more intensely than their differentiated counterparts. Findings also demonstrated that receptors for epidermal growth factor, fibroblast growth factor, and plateletderived growth factor were present in the plasma membrane of keratinocytes. C-jun, a transcription factor was found in the nuclei of keratinocytes of the cholesteatoma epithelium. These findings indicate that ras protein plays a pivotal role in a signal transduction cascade between growth factor receptors in the plasma membrane and the transcription factor, c-jun, in the nuclei of keratinocytes during the growth of cholesteatoma.
Similar articles
-
[The expression of Ras protein in human middle ear cholesteatoma].Zhonghua Er Bi Yan Hou Ke Za Zhi. 1999 Apr;34(2):74-6. Zhonghua Er Bi Yan Hou Ke Za Zhi. 1999. PMID: 12764851 Chinese.
-
Expressions of c-jun and p53 proteins in human middle ear cholesteatoma: relationship to keratinocyte proliferation, differentiation, and programmed cell death.Laryngoscope. 1995 Nov;105(11):1232-7. doi: 10.1288/00005537-199511000-00018. Laryngoscope. 1995. PMID: 7475882
-
Heat shock proteins in middle ear cholesteatoma.Otolaryngol Head Neck Surg. 1996 Jan;114(1):77-83. doi: 10.1016/S0194-59989670287-5. Otolaryngol Head Neck Surg. 1996. PMID: 8570255
-
[The research progress of keratin's roles in the pathology of middle ear cholesteatoma].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Nov 7;54(11):870-874. doi: 10.3760/cma.j.issn.1673-0860.2019.11.014. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019. PMID: 31795552 Review. Chinese.
-
Keratinocyte growth factor signaling promotes stem/progenitor cell proliferation under p63 expression during middle ear cholesteatoma formation.Curr Opin Otolaryngol Head Neck Surg. 2020 Oct;28(5):291-295. doi: 10.1097/MOO.0000000000000655. Curr Opin Otolaryngol Head Neck Surg. 2020. PMID: 32796271 Review.
Cited by
-
Review of potential medical treatments for middle ear cholesteatoma.Cell Commun Signal. 2022 Sep 19;20(1):148. doi: 10.1186/s12964-022-00953-w. Cell Commun Signal. 2022. PMID: 36123729 Free PMC article. Review.
-
Upregulation of phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in acquired middle ear cholesteatoma growth.Int J Mol Sci. 2013 Jul 11;14(7):14439-59. doi: 10.3390/ijms140714439. Int J Mol Sci. 2013. PMID: 23852020 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous